Allianz stock: Barclays raises target but keeps Sell rating
Published on 11/18/2026 at 10:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBarclays raises target, keeps Sell
- Barclays lifted its Allianz price target while retaining a Sell rating.
- The revised target remains below the latest Allianz share price.
- The next scheduled full-year results are due on February 23, 2027.
Barclays raised its price target for Allianz to 385 euros from 351 euros on Tuesday, November 17, while retaining a Sell rating, according to MarketScreener, citing dpa-AFX Analyser.
Barclays' revised target is 81.50 euros below the latest Allianz share price referenced in the report. The higher valuation mark therefore came with a continued negative view on the stock rather than a change to a Buy or Hold recommendation.
Valuation remains the central issue
The analyst action follows Allianz's record nine-month operating result and its higher 2026 profit outlook. Allianz raised the upper end of its full-year operating-profit target to around 18.6 billion euros after operating profit reached 14.1 billion euros in the first nine months.
For investors, the combination of stronger earnings momentum and a cautious valuation view creates a split signal. Profit growth and the raised outlook support the operating case, while Barclays' target indicates that the bank sees limited room for the shares at current levels.
Allianz stock traded at 465.65 euros on Lang & Schwarz at 10:16 CET on Wednesday, November 18, 0.18 percent below the Xetra close of Tuesday, November 17.
Allianz SE at a glance
- Company: Allianz SE
- ISIN: DE0008404005
- Primary listing: Xetra
- Lang & Schwarz quote: 465.65 euros, Wednesday, November 18, 2026, 10:16 CET
- Xetra close: 466.50 euros, Tuesday, November 17, 2026
- Barclays price target: 385 euros, Sell rating
The next scheduled company checkpoint is Allianz's full-year 2026 results, listed for February 23, 2027. Until then, investors are likely to weigh the raised earnings outlook against valuation concerns from banks such as Barclays.
The DAX provides the broader German equity-market context for Allianz investors.
